Title : Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate.

Pub. Date : 1999 May

PMID : 10452644

1 Functional Relationships(s)
Compound Name
Protein Name
1 Children who began taking at least one new reverse transcriptase inhibitor near the time when nelfinavir mesylate was started, and those with a > or = 24% proportion of CD4 lymphocytes, had a greater chance of achieving and maintaining a decline in plasma HIV-1 RNA to < 400 copies/mL. Nelfinavir CD4 molecule Homo sapiens